Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD

PHARMACOGENOMICS & PERSONALIZED MEDICINE · Published 2024-04-01 · DOI 10.2147/pgpm.s455490

Authors being retrieved — see the publisher record. https://doi.org/10.2147/pgpm.s455490

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2024

Related articles